This study is a comparison between revised Manchester Point A and International Commission on Radiation Units and measurements (ICRU) 89 reporterecommended Point A absorbed-dose reporting in intracavitary brachytherapy for patients with cervical carcinoma.
METHODS AND MATERIALS:The retrospective dosimetric study is based on the data of 32 patients with cervical carcinoma treated with high-dose-rate brachytherapy. Patients received 21 Gy in three fractions (7.0 Gy X three fractions) to Point A (A flange , revised Manchester definition). All the patients were replanned with a new Point A (A icru89 ) defined on CT images as per the American Brachytherapy Society/ICRU-89. The data collected were compared with the data obtained from Point A (A flange ). RESULTS: When using the A flange plan normalization method, the mean dose of 0.1 cc, 1 cc, and 2 cc bladder volumes was 820.79